Is Monte Rosa Therapeutics, Inc. overvalued?

Monte Rosa Therapeutics, Inc. (GLUE) — key valuation metrics and fundamentals.

No verdict

Price

$24.26

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$1.56B

Dividend yield

—

Return on equity

—

Sector

Healthcare

Fair value compares GLUE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.

Related stocks